-
Mashup Score: 23
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC The Current Treatment Landscape in Metastatic Prostate Cancer – Andrew Armstrong Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Andrew Armstrong, MD, Professor of Medicine, Professor in Surgery, Professor in Pharmacology and Cancer Biology, Director of Research, Duke…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 76
Dr.
Source: p2p.conquer.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Prostate Cancer Screening Guidelines for Black Men - 10 day(s) ago
Sponsoring Organization: Prostate Cancer FoundationBackground and ObjectiveBlack men have both an extremely high incidence of prostate cancer and a
Source: www.jwatch.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 68
Dr.
Source: p2p.conquer.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 68
Dr.
Source: p2p.conquer.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 11
At the 2024 UCSF-UCLA PSMA Conference, Amar Kishan presents on metastasis-directed therapy (MDT) for oligometastatic prostate cancer, highlighting its potential to delay systemic therapy and improve progression-free survival (PFS) as evidenced by trials like STOMP, ORIOLE, EXTEND, and ARTO. Dr. Kishan emphasizes the role of PSMA PET imaging in identifying MDT candidates and calls for further…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 7
At the 2024 UCSF-UCLA PSMA Conference, Louise Emmett explores the interaction between PSMA and androgen receptors in prostate cancer, focusing on their role across different disease states and the impact on treatment and imaging. Dr. Emmett highlights the ENZA-P trial, a study investigating the combination of Enzalutamide with Lutetium PSMA in metastatic castrate-resistant prostate cancer,…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 16
Finding out that cancer has spread is always unwelcome news. A study from Aarhus University has identified a gene that determines whether patients with prostate cancer develop metastases elsewhere in …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 22Optimizing Salvage Radiation Therapy in Prostate Cancer: New AUA/ASTRO/SUO Guideline - Todd Morgan - 13 day(s) ago
Zach Klaassen speaks with Todd Morgan about innovative approaches in the management of prostate cancer post-prostatectomy. Dr. Morgan presents compelling new data on the prostate AI test, highlighting its use in identifying biochemical recurrence after prostatectomy. This AI model, validated with data from key trials, not only distinguishes patients based on the aggressiveness of their disease…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2
Dan George discusses the collaborative effort in managing PLUVICTO® therapy for prostate cancer with team members Kristen Davis and Sarah Wood. Dr. Davis describes the meticulous process of vetting patients for PLUVICTO® therapy, which includes reviewing patient information, scans, and coordinating with various departments for approval. Dr. Wood outlines her role in educating and managing…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Operationalizing and coordinating lutetium-177 PSMA treatment: roles of a multidisciplinary #ProstateCancer team. Kristen Davis, Sarah Yenser Wood, and @Daniel_J_George @DukeCancer underline the importance of a team approach and effective communication > https://t.co/sC6IxJAzNn https://t.co/Rzxf0yPPMl
-
The current treatment landscape in metastatic #ProstateCancer. @AarmstrongDuke @DukeCancer joins @CaPsurvivorship to discuss in this Independent Medical Education Initiative Supported by @LoxoLillyOnc on UroToday > https://t.co/u5yPGSfdLS https://t.co/NqnL0aj4E8